Latest ArticlesUtility measurement is one of the important indicators reflecting health outcomes in pharmacoeconomic evaluation, and it has a large impact on the results of pharmacoeconomic evaluation. This paper analyzed and discussed several considerations of utility measurement defined in guidelines for pharmacoeconomic evidence submission in typical countries (regions), from the six aspects of utility indicators, target populations for utility measurement, utility measurement tools, types of multi-attribute utility instruments, utility value sets and sources of utility data. It was suggested that quality adjusted life years should be used as the utility index in the cost-utility analysis for adjustments of Chinese (except Hong Kong, Macao and Taiwan) medical insurance drug list, and the indirect methods should be used to measure the utility weights for general populations. In addition, the priority of different data sources of utility weights should be clarified.
Pharmacoeconomic evaluation is an important reference evidence for the adjustment and decision-making of national reimbursement drug list in each country or region. The value of the discount rate can heavily affect the pharmacoeconomic evaluation results, so it needs to be further standardized. Based on the submission guidelines of typical countries and regions, this paper analyzed the connotation and characteristics of the discount rate and explored the theoretical basis and calculation method, so as to provide reference for the development of discount rate of pharmacoeconomic evaluation to support the adjustment of reimbursement drug list in China (except Hong Kong, Macao and Taiwan).
Time horizon has a direct impact on the "incremental cost-effectiveness ratio" of pharmacoeconomic evaluation results. There are no clear requirements or explanations on the setting method of time horizon in the guidance documents related to pharmacoeconomic evaluation, such as national health policies and pharmacoeconomic evaluation guidelines. Based on the official specifications of typical countries and regions, the paper analyzed the characteristics and descriptions of different official specifications on time horizon. It was suggested that China (except Hong Kong, Macao and Taiwan) should pay attention to the detailed explanation of the determinants of the selection of time horizon and the rationality of the selection results when conducting pharmacoeconomic evaluation based on official specifications, and present the uncertainty analysis of time horizon and the corresponding results in the submission guidelines.
To explore the effects and molecular mechanism of repaglinide on podocyte injury induced by high glucose.
Podocytes from conditionally immortal mice were divided into control group (5.5 mmol/L glucose), high glucose group (30 mmol/L glucose), experimental group 1 (30 mmol/L glucose+0.25 μmoL/L repaglinide), experimental group 2 (30 mmol/L glucose+0.50 μmoL/L repaglinide) and experimental group 3 (30 mmol/L glucose+1.00 μmoL/L repaglinide). Cell viability and apoptosis were detected by cell counting kit and flow cytometry. The levels of malondialdehyde (MDA) and transforming growth factor β1 (TGF-β1) in cells were detected by the kit. Real-time fluorescence PCR and western blot were used to detect the expression of sodium-glucose linked transporter 2 (SGLT2). SGLT2 overexpression plasmid was transfected into podocyte cells, and the changes of the above indicators were detected after intervention with high glucose and repaglinide.
Compared with the control group, podocyte survival rate and expression of Ki67 protein in the high glucose group were decreased, apoptosis rate, MDA, TGF-β1 levels and expression of SGLT2 were increased (P<0.05). Compared with the high glucose group and experimental group 1, podocyte survival rate and expression of Ki67 protein in the experimental group 2 and 3 were increased, and the apoptosis rate, MDA, TGF-β1 levels and expression of SGLT2 were decreased (P<0.05). Compared with the experimental group 2, the podocyte survival rate and expression of Ki67 protein in the experimental group 3 were increased, and the apoptosis rate, MDA, TGF-β1 levels and expression of SGLT2 were decreased (P<0.05). Overexpressing SGLT2 partially reversed the protective effects of repaglinide on podocyte injury induced by high glucose (P<0.05).
Repaglinide has a protective effect on podocyte injury induced by high glucose, which may be related to down-regulation of expression of SGLT2.
To investigate the effects and mechanism of baicalin on pulmonary function in bronchiectasis rats based on interleukin (IL)-23/IL-17 axis.
A total of 65 SD rats were selected, 10 of which were used as the control group without any intervention, and the rest rats were injected with Pseudomonas aeruginosa to construct the bronchiectasis rat model. Five rats were used to confirm the modeling results. The remaining 50 rats were randomly divided into model group, low-dose (50 mg/kg), medium-dose (100 mg/kg), high-dose (200 mg/kg) baicalin group and positive control (levofloxacin, 96.7 mg/kg) group, with 10 rats in each group. After 14 days of intervention, pulmonary function indexes of rats in each group were measured. The levels of IL-23 and IL-17 in serum and the contents of matrix metalloproteinase (MMP)9 and tissue inhibitor of metalloproteinase (TIMP)-1 in lung tissue were detected by enzyme linked immunosorbent assay (ELISA). Hematoxylin and eosin (HE) staining was used to observe the pathological changes of lung tissue in each group. Western blot (WB) was used to detect the protein expression levels of IL-23 and IL-17 in the lung tissue of rats in each group.
Compared with the model group, the inflammatory cell infiltration, bronchiectasis, alveolar structure damage in the lung tissue of rats in the low-dose, medium-dose and high-dose baicalin groups were relieved to varying degrees, the lung function index and TIMP-1 content were increased (P<0.01), and the levels of MMP-9, IL-23, IL-17 and the expression of IL-23, IL-17 protein were decreased (P<0.01). There were no significant differences in the indexes between the high-dose baicalin group and the positive control group (P>0.05).
Baicalin may reduce the inflammatory level and lung tissue injury in bronchiectasis rats and improve lung function by inhibiting the IL-23/IL-17 axis.
To study the clinical effects of Qizhen granules on patients with type 2 diabetes mellitus (T2DM) of Qi deficiency type and abdominal obesity with concept of "treating different diseases with same method".
A total of 60 patients with T2DM of Qi deficiency type and 60 patients with abdominal obesity were included in the inpatient and outpatient departments of endocrinology, Yueyang hospital of integrated traditional Chinese and western medicine, Shanghai university of traditional Chinese medicine (TCM) from January 2018 to December 2019. The two types of patients were randomly divided into observation group and control group, with 30 cases in each group. On the basis of diet, exercise therapy and maintaining the original hypoglycemic regimen in T2DM group, Qizhen granules and control drug were added to the observation group and control group respectively. On the basis of diet and exercise therapy, the observation group and the control group were treated with Qizhen granules and control drug respectively. The course of treatment was 12 weeks. The indexes of saccharometabolism in T2DM group and the physique in abdominal obesity group were observed before and after treatment. The homeostasis model assessment of insulin resistance (HOMA-IR) was compared between the two groups of patients.
After treatment, fasting blood glucose, 2-hour postprandial blood glucose and glycosylated hemoglobin in the T2DM observation group were significantly lower than those in the T2DM control group (P<0.01). And the observation group was better than the control group, the difference was statistically significant (P<0.05). The body mass index, waist circumference and waist hip of the abdominal obesity observation group were significantly improved compared with those before treatment (P<0.01), and the observation group was better than the control group (P<0.01). HOMA-IR in the two groups decreased significantly (P<0.01), And the observation group was better than the control group, the difference was statistically significant (P<0.05). The curative effect of TCM syndromes in the observation group was better than that in the corresponding control group, and the difference was statistically significant (P<0.01).
Qizhen granules can treat different diseases at the same time for patients with T2DM of syndrome of Qi deficiency and abdominal obesity with concept of "treating different diseases with same method", and it may improve IR and symptoms by supplementing Qi.
To investigate the effects of diterpene ginkgolides meglumine on blood homocysteine (Hcy), angiotensin-Ⅱ (Ang-Ⅱ) and neurological function in acute cerebral infarction (CI) patients with CYP2C19 mutation.
A total of 82 acute CI patients with CYP2C19 mutation who were treated in Dalian No.3 people's hospital from January 2018 to April 2020 were selected and divided into the control group (n=41) and the observation group (n=41), using the random number table method. The control group was given aspirin and clopidogrel, and the drug dose was increased. And the observation group was additionally given diterpene ginkgolides meglumine. The platelet function, hemorheology, Hcy, Ang-Ⅱ and nerve function were compared between the two groups before and after treatment.
Before treatment, there were no significant differences in CD62p, CD63 and platelet aggregation rate, hemorheology related, Hcy and Ang-Ⅱ levels, and neurological function-related indexes between the two groups (P>0.05). After treatment, the levels of CD62p, CD63, platelet aggregation rate, hemorheology-related indexes, Hcy and Ang-Ⅱ levels in the observation group were significantly lower than those in the control group (P<0.05), while the levels of brain-derived neurotrophic factor in the observation group were significantly higher than those in the control group (P<0.05). There were statistically significant differences in the above indexes between the observation group and the control group before and after treatment (P<0.05). After treatment, the neuron-specific enolase level and the National Institutes of Health Stroke Scale score were significantly lower than those in the control group (P<0.05), and there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
Diterpene ginkgolides meglumine can effectively improve platelet function and hemorheological indexes, down regulate the levels of Hcy and Ang-Ⅱ, relieve the symptoms of neurological deficit and improve neurological function in acute CI patients with CYP2C19 mutation.
To observe and analyze the clinical effects of Jianpi Xiaoying decoction on thyroid peroxidase autoantibody (TPOAb), thyroglobulin antibody (TGAb), estradiol (E2), prolactin (PRL) and progestogen (P) in women of childbearing age with Hashimoto thyroiditis (HT).
Women of childbearing age with HT diagnosed in the outpatient and inpatient department of endocrinology, LongHua hospital Shanghai university of traditional chinese medicine from October 2019 to December 2020 were randomly divided into observation group (n=32, Jianpi Xiaoying decoction) and control group (n=31, selenium yeast). The course of treatment was 12 weeks. The improvement of symptoms, signs and laboratory indexes were observed before and after treatment.
The levels of TPOAb and TGAb in the two groups were lower than those before treatment (P<0.01), and the observation group was better than the control group (P<0.05). The levels of E2 and P in the observation group were significantly higher than those before treatment (P<0.01), and the observation group was better than the control group (P<0.01). The PRL in both groups was lower than before treatment (P<0.01), and the observation group was better than that of the control group (P<0.01). The clinical symptoms and signs of the two groups were significantly improved compared with those before treatment (P<0.01), and the observation group was better than the control group (P<0.01). The curative effects of the control group was significantly better than those of the control group, the difference was statistically significant (P<0.01).
Jianpi Xiaoying decoction can significantly reduce the titers of autoantibodies TPOAb and TGAb in women of childbearing age with HT, improve the clinical symptoms and signs, and regulate the level of sex hormones in patients with better safety.
To observe effects of azithromycin combined with interferon-α(IFN-α) on mycoplasma pneumoniae pneumonia (MPP).
A total of 170 children with MPP diagnosed in Tongling maternal and child health hospital from November 2018 to August 2019 were selected. They were randomly divided into control group and observation group. The control group was given azithromycin and the observation group was given azithromycin combined with IFN-α. The curative effect and the changes of granulocyte-macrophage colony stimulating factor (GM-CSF) and serum amyloid A (SAA) were observed before and after treatment. The airway reactivity was observed by hypertonic saline bronchial provocation test.
After treatment, GM-CSF of the observation group was lower than that of control group (P<0.05). Forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), peak expiratory flow (PEF) and maximum mid expiratory flow (MMEF) decreased. The △FVC of the observation group was (5.07±4.32), lower than that of the control group (7.24±5.92), the △MMEF (12.17±7.33) was lower than that of the control group (16.23±8.81) (P<0.05). The total effective rate of observation group (88.23%) was higher than that of control group (69.41%)(P<0.05).
Compared with azithromycin, azithromycin combined with IFN-α can achieve better curative effect and reduce airway responsiveness in children with MPP.
To investigate the effect of conversion of efavirenz (EFV) to rilpivirine (RPV) on blood lipids in adult human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients.
The clinical data of 67 patients with HIV/AIDS who were converted from EFV to RPV in Beijing Youan hospital, capital medical university, from March 2019 to September 2021 were retrospectively analyzed. The HIV viral load, CD4 cell count, blood lipid, liver and kidney function before and after RPV conversion were compared.
After the conversion, the levels of triglycerides (TG), total cholesterol (TC) and high density lipoprotein-cholesterol (HDL-C) decreased, and the differences were statistically significant (P<0.05). The level of low density lipoprotein-cholesterol (LDL-C) decreased, but the difference was not statistically significant (P>0.05). After the conversion, the total abnormal rate of total blood lipid was increased, and the abnormal rates of TC and LDL-C decreased, but the differences were not statistically significant (P>0.05). The abnormal rate of TG decreased from 52.24% to 32.84%, and the abnormal rate of HDL-C increased from 31.34% to 68.66%, the differences were statistically significant (P<0.05). The absence of tenofovir in regimens was a risk factor for elevated LDL-C. After conversion, the levels of alanine aminotransferase, glutamine aminotransferase and creatinine decreased, and the differences were statistically significant (P<0.05).
RPV can significantly reduce TG and TC, but also reduce the level of HDL-C. Its benefit in blood lipid still needs more research.